Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis

Patients with chronic pancreatitis (CP) are at risk of developing pancreatic ductal adenocarcinoma (PDAC). To the best of our knowledge, there are no suitable non-invasive biomarkers for differentiation between CP and PDAC; however, potential molecular candidates include circulating miRNAs due to ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Guz, Małgorzata, Jeleniewicz, Witold, Cybulski, Marek, Kozicka, Joanna, Kurzepa, Jacek, Mądro, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678635/
https://www.ncbi.nlm.nih.gov/pubmed/33235725
http://dx.doi.org/10.3892/br.2020.1386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678635/
https://www.ncbi.nlm.nih.gov/pubmed/33235725
http://dx.doi.org/10.3892/br.2020.1386

Ejemplares similares